Skip to main content
. 2014 Sep 9;2(6):831–834. doi: 10.3892/br.2014.359

Figure 3.

Figure 3

(A) Representative immunoblots and (B) content changes of glutamate cysteine ligase modulatory subunit (GCLm) are indicated from renal cell carcinoma (RCC) patients and the control group. Data are expressed as mean ± standard error. **P<0.01. WB, western blotting.